bpc 157 safety toxicity studies What is BPC-157? Peptide BPC-157 - Does It

No peptide discussed in this guide has received FDA approval for treating multiple sclerosis

Likewise, acting through the NO-system, BPC 157 counteracted various opposite disturbances, i.e., prolonged miosis and prolonged mydriasis [111], consequences of hyperkalemia and hypokalemia [3], hypertension and hypotension [152], and bleeding and thrombosis [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168]

When injecting locally near the wrist, move the exact injection point by at least half an inch between doses

That's exactly why it belongs in a supervised program, not a self-experiment

doi: 10.1093/brain/awq359

but see Lalley et al., 2014